149 related articles for article (PubMed ID: 11882917)
1. Supersensitivity of 5-HT1A autoreceptors and alpha2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):210-9. PubMed ID: 11882917
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.
Moranta D; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):61-72. PubMed ID: 18709357
[TBL] [Abstract][Full Text] [Related]
3. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
Esteban S; Moranta D; Sastre-Coll A; Miralles A; García-Sevilla JA
Neurosci Lett; 2002 Jun; 326(2):121-4. PubMed ID: 12057843
[TBL] [Abstract][Full Text] [Related]
5. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
Esteban S; Lladó J; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):391-9. PubMed ID: 8935705
[TBL] [Abstract][Full Text] [Related]
7. The alpha 2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo.
Lladó J; Esteban S; García-Sevilla JA
Neurosci Lett; 1996 Nov; 218(2):111-4. PubMed ID: 8945740
[TBL] [Abstract][Full Text] [Related]
8. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
9. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
Chaouloff F; Aguerre S; Mormede P
Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.
Ahlenius S; Hillegaart V; Salmi P; Wijkström A
Pharmacol Toxicol; 1993 Jun; 72(6):398-406. PubMed ID: 8361951
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
12. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
13. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
15. In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors.
Ahlenius S; Henriksson I; Magnusson O; Salmi P
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):15-9. PubMed ID: 10082223
[TBL] [Abstract][Full Text] [Related]
16. Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain.
Brambilla A; Baschirotto A; Grippa N; Borsini F
Eur Neuropsychopharmacol; 1999 Dec; 10(1):63-7. PubMed ID: 10647099
[TBL] [Abstract][Full Text] [Related]
17. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.
Baumann MH; Rothman RB
Biol Psychiatry; 1998 Oct; 44(7):578-91. PubMed ID: 9787882
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
